Research Progress on the Structure and Function, Immune Escape Mechanism, Antiviral Drug Development Methods, and Clinical Use of SARS-CoV-2 Mpro
Molecules,
Год журнала:
2025,
Номер
30(2), С. 351 - 351
Опубликована: Янв. 16, 2025
The
three-year
COVID-19
pandemic
‘has’
caused
a
wide
range
of
medical,
social,
political,
and
financial
implications.
Since
the
end
2020,
various
mutations
variations
in
SARS-CoV-2
strains,
along
with
immune
escape
phenomenon,
have
emerged.
There
is
an
urgent
need
to
identify
relatively
stable
target
for
development
universal
vaccines
drugs
that
can
effectively
combat
both
strains
their
mutants.
Currently,
main
focus
treating
lies
disrupting
virus’s
life
cycle.
protease
(Mpro)
closely
associated
virus
replication
maturation
plays
crucial
role
early
stages
infection.
Consequently,
it
has
become
important
SARS-CoV-2-specific
drugs.
This
review
summarizes
recent
research
progress
on
novel
coronavirus’s
proteases,
including
pivotal
Mpro
cycle,
structure
catalytic
mechanism
Mpro,
self-maturation
escape,
current
methods
developing
antiviral
targeting
key
successfully
entered
clinical
trials.
aim
provide
researchers
involved
systematic
comprehensive
information.
Язык: Английский
Rifampicin Repurposing Reveals Anti-Melanogenic Activity in B16F10 Melanoma Cells
Molecules,
Год журнала:
2025,
Номер
30(4), С. 900 - 900
Опубликована: Фев. 15, 2025
Drug
repurposing
is
a
cost-effective
and
innovative
strategy
for
identifying
new
therapeutic
applications
existing
drugs,
thereby
shortening
development
timelines
accelerating
the
availability
of
treatments.
Applying
this
approach
to
cosmeceutical
ingredients
enables
creation
functional
compounds
with
proven
safety
efficacy,
adding
significant
value
cosmetic
industry.
This
study
evaluated
potential
rifampicin,
drug
widely
used
treatment
tuberculosis
leprosy,
as
agent.
The
anti-melanogenic
effects
rifampicin
were
assessed
in
B16F10
melanoma
cells,
showing
no
cytotoxicity
at
concentrations
up
40
µM
reduction
intracellular
tyrosinase
activity
melanin
content.
Mechanistically,
reduced
expression
melanogenic
enzymes,
including
tyrosinase,
tyrosinase-related
protein
(TRP)-1,
TRP-2,
via
kinase
A
(PKA)-dependent
pathway,
leading
suppression
microphthalmia-associated
transcription
factor
(MITF),
which
key
regulator
melanogenesis.
Additionally,
inhibited
p38
signaling
pathway
but
was
independent
PI3K/protein
B
(Akt)
pathway.
Furthermore,
it
decreased
Ser9
phosphorylation,
enhancing
glycogen
synthase
kinase-3β
(GSK-3β)
activity,
promoted
β-catenin
facilitated
degradation,
collectively
contributing
inhibition
synthesis.
To
evaluate
topical
applicability
primary
human
skin
irritation
tests
conducted,
adverse
observed
20
µM.
These
findings
demonstrate
that
inhibits
melanogenesis
through
multiple
pathways,
PKA,
MAPKs,
GSK-3β/β-catenin.
highlights
be
repurposed
agent
managing
hyperpigmentation
disorders,
offering
valuable
insights
into
novel
strategies
pigmentation-related
conditions.
Язык: Английский
Coating of Remdesivir and Ivermectin on Silver Nanoparticles: A Density Functional Theory and Molecular Dynamics Study
Results in Surfaces and Interfaces,
Год журнала:
2025,
Номер
unknown, С. 100540 - 100540
Опубликована: Апрель 1, 2025
Язык: Английский
Brief research report: Transcriptional blockade of angiotensin converting enzyme 2 modelled in human retinal pigment epithelial cells
Frontiers in Drug Discovery,
Год журнала:
2024,
Номер
4
Опубликована: Окт. 7, 2024
As
a
key
host
protein
involved
in
cellular
infection
by
the
severe
acute
respiratory
syndrome
coronavirus
(SARS-CoV-2),
angiotensin
converting
enzyme
(ACE)2
is
an
ideal
target
for
antiviral
drugs.
Manipulation
of
transcription
provides
opportunity
graduated
blockade
that
preserves
physiological
functions.
We
sought
to
develop
model
system
evaluating
manipulation
ACE2
gene
using
human
retinal
pigment
epithelium.
Retinal
epithelial
cell
isolates
were
prepared
from
posterior
eyecups
(n
=
11
individual
isolates).
The
cells
expressed
transcript
and
protein,
expression
was
not
induced
hypoxia
mimetic
dimethyloxaloylglycine,
or
inflammatory
cytokine
IL-1β.
factors
predicted
silico
cross-referenced
with
transcriptome,
five
candidate
identified:
ETS
proto-oncogene
1
factor
(ETS1),
nuclear
I
C
(NFIC),
receptor
subfamily
2
group
member
(NR2C1),
TEA
domain
(TEAD1),
zinc
finger
384
(ZNF384).
candidates
individually
targeted
transfection
small
interfering
(si)RNA.
Knockdowns
reduced
mean
all
comparison
transfected
control
non-targeted
siRNA.
Mean
under
condition
NR2C1
knockdown,
but
ETS1,
NFIC,
TEAD1,
ZNF384
knockdowns.
Our
findings
build
on
previous
work
demonstrating
potential
drugging
transcription.
Importantly,
we
show
value
epithelium
as
transcriptional
blockade,
possible
approach
treating
SARS-CoV-2
infection.
Brief
Research
Report.
Язык: Английский